ClinicalTrials.Veeva

Menu

Comparison of Three Pre-oxygenation Strategies

I

Institute of Mountain Emergency Medicine

Status

Enrolling

Conditions

Emergencies
Anesthesia

Treatments

Other: Preoxygenation

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

Study objective: Comparing the efficacy of three different preoxygenation strategies, i.e. non-rebreather face mask (NRM), bag-valve-mask (BVM) with and BVM without additional positive end-expiratory pressure (PEEP) in three subgroups of spontaneously breathing volunteers.

Study endpoints

Primary Endpoint:

Difference in expiratory oxygen concentration (FeO2) at the end of the 3 min preoxygenation sessions.

Secondary endpoints:

  • Difference in Oxygen Reserve Index (ORi) at the end of the 3 min preoxygenation sessions.
  • Changes in regional ventilation from baseline to 1.5 min and 3 min into the preoxygenation sessions, assessed using electrical impedance tomography (EIT)
  • Time to reaching an Oxygen Reserve Index (ORi) ≥ 0.5
  • Time to reaching an Oxygen Reserve Index (ORi) =1
  • Time to Oxygen Reserve Index (ORi) back to baseline after the 3 min preoxygenation sessions.

Number of participants 15 participants per subgroup, i.e. 45 participants in total.

Inclusion criteria

  • Normal-weight adults (body mass index, BMI 18.5-24.9 kg/m2) with an "American Society of Anesthesiologists Physical Status Classification System (ASA) " score of I or II
  • Adults with a BMI 25-39.9 kg/m2 with and ASA score <3
  • Healthy (ASA I) children aged 6-12 years Exclusion criteria ASA 3, Age < 6 and age 12-18, pregnant women, missing informed consent, signs and symptoms of an acute respiratory illness on the study day.

After informed consent and a medical check-up, baseline measurements will be done for 10 minutes (peripheral oxygen saturation SpO2, ORI, regional ventilation). Then the participants will undergo 3 different preoxygenation sessions with the 3 interfaces (i.e. non-rebreather facemask with reservoir and a bag-valve-mask with and without PEEP) in a randomized order and a 20 min washout between the sessions. Each preoxygenation session is conducted in a supine position and will be proceeded until the measured FeO2 (end expiratory O2 fraction) reaches 90% or up to a maximum time of 3 min. Afterwards 10 min of SpO2, ORI and regional ventilation measurements will follow.

Enrollment

45 estimated patients

Sex

All

Ages

6+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Normal-weight adults (BMI 18.5-24.9 kg/m2) with an "American Society of Anesthesiologists Physical Status Classification System (ASA) " score of I or II
  • Adults with a BMI 25-39.9 kg/m2 with and ASA score <3
  • Healthy (ASA I) children aged 6-12 years

Exclusion criteria

  • ASA 3
  • Age < 6 and age 12-18
  • pregnant women
  • missing informed consent
  • signs and symptoms of an acute respiratory illness on the study day

Trial design

Primary purpose

Other

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

None (Open label)

45 participants in 9 patient groups

NRM - Non-rebreather mask in children 6-12 yrs
Active Comparator group
Description:
Non-rebreather mask in children 6-12 yrs
Treatment:
Other: Preoxygenation
BVM with PEEP in children 6-12 yrs
Active Comparator group
Description:
Bag valve mask with positive end-expiratory pressure (PEEP) in children 6-12 yrs
Treatment:
Other: Preoxygenation
BVM without PEEP in children 6-12 yrs
Active Comparator group
Description:
Bag valve mask without positive end-expiratory pressure (PEEP) in children 6-12 yrs
Treatment:
Other: Preoxygenation
NRM - Non-rebreather mask in normal weight adults
Active Comparator group
Description:
Non-rebreather mask in normal weight adults
Treatment:
Other: Preoxygenation
BVM with PEEP in normal weight adults
Active Comparator group
Description:
Bag valve mask with positive end-expiratory pressure (PEEP) in normal weight adults
Treatment:
Other: Preoxygenation
BVM without PEEP in normal weight adults
Active Comparator group
Description:
Bag valve mask without positive end-expiratory pressure (PEEP) in normal weight adults
Treatment:
Other: Preoxygenation
NRM - Non-rebreather mask in overweight/obese adults
Active Comparator group
Description:
Non-rebreather mask in overweight/obese adults
Treatment:
Other: Preoxygenation
BVM with PEEP in overweight/obese adults
Active Comparator group
Description:
Bag valve mask with positive end-expiratory pressure (PEEP) in overweight/obese adults
Treatment:
Other: Preoxygenation
BVM without PEEP in overweight/obese adults
Active Comparator group
Description:
Bag valve mask without positive end-expiratory pressure (PEEP) in overweight/obese adults
Treatment:
Other: Preoxygenation

Trial contacts and locations

1

Loading...

Central trial contact

Simon Rauch, MD, PhD; Giulia Roveri, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems